Entering text into the input field will update the search result below

Laboratory Corporation of America reports mixed Q1 earnings; narrows FY23 EPS outlook

  • Laboratory Corporation of America press release (NYSE:LH): Q1 Non-GAAP EPS of $3.82 misses by $0.14.
  • Revenue of $3.8B (-2.6% Y/Y) beats by $100M.
  • Free Cash Flow: Q1 of $27 million versus $239 million last year
  • Planned spin of Clinical Development business remains on schedule for mid-2023.
  • Full-Year 2023 Guidance: Adjusted EPS narrowed to $16.25 to $17.75 with midpoint unchanged vs. consensus of $17.30 and Free Cash Flow remains at $1.0 billion to $1.2 billion

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

biochemist profile picture
LH got hammered today on these bad numbers.

About LH

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Laboratory Corporation of America Holdings
Fresenius SE & Co. KGaA
Quest Diagnostics Incorporated
Fresenius Medical Care AG & Co. KGaA
DaVita Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.